Johnson & Johnson (JNJ)
219.67
+1.18
(+0.54%)
USD |
NYSE |
Jan 23, 13:47
Johnson & Johnson EPS Diluted (Quarterly): 2.098 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 5.934 |
| Gilead Sciences, Inc. | 2.434 |
| Intuitive Surgical, Inc. | 2.21 |
| Eli Lilly & Co. | 6.211 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 5.116B |
| Revenue (Quarterly) | 24.56B |
| Total Expenses (Quarterly) | 19.45B |
| Enterprise Value | 553.64B |
| Gross Profit Margin (Quarterly) | 72.39% |
| Profit Margin (Quarterly) | 20.83% |
| Earnings Yield | 5.03% |
| Operating Earnings Yield | 4.85% |
| Normalized Earnings Yield | 4.218 |